Key facts
- It has raised $2.7M; the latest was Early Stage VC ($700K) in Jan 2025.
- Notable investors include PeakBridge, Ratio technologies (Israel), Shay Livnat.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Evinature
- ·The full record, as it builds
Funding rounds
No funding rounds for Evinature are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Evinature
Operator of a digital healthcare platform intended to provide people around the world with safe and affordable medicine. The company's platform offers natural, evidence-based supplements and tailored treatment plans for the IBD community, providing patients and consumers with modern medical practice as well as herbal remedies and ensuring the standard of scientific safety and ingredients.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Bergen County, NJ, United States
- Founded
- 2021
- Employees
- 20
- Website
- evinature.com/
- Ownership
- Privately Held (backing)
Evinature doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Evinature shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Evinature in its N-PORT filings yet. We sweep new filings monthly.